| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/06/2013 | WO2012153266A3 Method for fabricating a microneedle, and produced microneedle |
| 06/06/2013 | WO2012137054A9 Pharmaceutical composition containing cyclobenzaprine suitable to intranasal administration |
| 06/06/2013 | WO2012059724A8 Formulations comprising polyethylene glycol |
| 06/06/2013 | US20130144370 Cochlear implant drug delivery device |
| 06/06/2013 | US20130144261 Structures for transdermal drug delivery |
| 06/06/2013 | US20130144250 Implantable drug delivery compositions and methods of treatment thereof |
| 06/06/2013 | US20130143991 Water-soluble pressure sensitive adhesives |
| 06/06/2013 | US20130143979 Precursor composition for crosslinkable pressure-sensitive adhesive for skin |
| 06/06/2013 | US20130143970 Medicinal preparation particularly for the treatment of slipped discs hernias |
| 06/06/2013 | US20130143965 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 06/06/2013 | US20130143938 Compositions and Methods for the Treatment of Migraine |
| 06/06/2013 | US20130143937 Chlorthalidone combinations |
| 06/06/2013 | US20130143912 Sublingual zolpidem formulations |
| 06/06/2013 | US20130143894 Oral spray formulations ad methods for administration of sildenafil |
| 06/06/2013 | US20130143872 Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer |
| 06/06/2013 | US20130143853 Oral suspension of prednisolone acetate |
| 06/06/2013 | US20130143851 Testosterone Solutions for the Treatment of Testosterone Deficiency |
| 06/06/2013 | US20130143849 Use of ciclesonide for the treatment of respiratory diseases |
| 06/06/2013 | US20130143844 Ectoparasiticide-containing preparation for spontaneous emulsion formation |
| 06/06/2013 | US20130143839 Cystitis treatment with high dose chondroitin sulfate |
| 06/06/2013 | US20130143801 Methods and compositions for delivering peptides |
| 06/06/2013 | US20130143740 Absorbent composition for surface treatment |
| 06/06/2013 | US20130142880 Beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and process for obtaining them |
| 06/06/2013 | US20130142879 Suspension formulations |
| 06/06/2013 | US20130142878 Peptide particle formulation |
| 06/06/2013 | US20130142876 Amphipathic lipid-based sustained release compositions |
| 06/06/2013 | US20130142875 Methods and compositions for treating prostate cancer |
| 06/06/2013 | US20130142874 Pharmaceutical compositions based on diclofenac |
| 06/06/2013 | US20130142870 Neramexane multiple unit dosage form |
| 06/06/2013 | US20130142868 Circumferential Aerosol Device for Delivering Drugs to Olfactory Epithelium and Brain |
| 06/06/2013 | US20130142867 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 06/06/2013 | US20130142864 In vivo targeting of dendritic cells |
| 06/06/2013 | US20130142863 Phosphatidylcholine lipid liposomes as boundry lubricants in aqueous media |
| 06/06/2013 | US20130142862 Tumor-Specific Delivery of Therapeutic Agents Via Liposomase |
| 06/06/2013 | US20130142860 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine |
| 06/06/2013 | US20130142859 Compositions and methods for the sustained release of beta-alanine |
| 06/06/2013 | US20130142858 Drug delivery devices for delivery of ocular therapeutic agents |
| 06/06/2013 | US20130142852 Nanofiber laminate sheet |
| 06/06/2013 | US20130142851 Compositions Comprising Components Coated With a Liquid Impermeable but Gas Permeable Layer, Use Thereof for Treating Cutaneous and Other Exocrine Gland Diseases |
| 06/06/2013 | US20130142848 Preparation for treatment of spinal cord injury |
| 06/06/2013 | US20130142846 Modified Release Analgesic Suspensions |
| 06/06/2013 | US20130142845 Use of a combination of an opioid agonist and an opioid antagonist for the treatment of crohn's disease and the symptoms associated with crohn's disease |
| 06/06/2013 | US20130142843 Calcium Carbonate Granulation |
| 06/06/2013 | US20130142842 Calcium Carbonate Granulation |
| 06/06/2013 | US20130142841 Calcium Carbonate Granulation |
| 06/06/2013 | US20130142833 Circulation of components during homogenization of emulsions |
| 06/06/2013 | US20130142782 Humidified particles comprising a therapeutically active substance |
| 06/06/2013 | US20130142770 Botulinum toxin compositions and methods |
| 06/06/2013 | US20130142733 Multifunctional degradable nanoparticles with control over size and functionalities |
| 06/06/2013 | CA2857747A1 Treatment of b cell lymphomas |
| 06/06/2013 | CA2857592A1 Composition based on ubidecarenone |
| 06/06/2013 | CA2857582A1 Coated condom |
| 06/06/2013 | CA2857567A1 Targeted lysosomal enzyme compounds |
| 06/06/2013 | CA2857548A1 Targeted enzyme compounds and uses thereof |
| 06/06/2013 | CA2857501A1 Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same |
| 06/06/2013 | CA2857457A1 Dry coated tablet |
| 06/06/2013 | CA2857156A1 Ropinirole-containing adhesive patch |
| 06/06/2013 | CA2857155A1 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use |
| 06/06/2013 | CA2856794A1 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
| 06/06/2013 | CA2856789A1 Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition |
| 06/06/2013 | CA2856529A1 Compositions and methods for treating hepatitis c virus |
| 06/06/2013 | CA2854194A1 Mmp-targeted therapeutic and/or diagnostic nanocarriers |
| 06/06/2013 | CA2854054A1 Amphipathic lipid-based sustained release compositions |
| 06/06/2013 | CA2850906A1 Transdermal therapeutic system for administering fentanyl or an analogue thereof |
| 06/05/2013 | EP2599517A1 Drug support body, and method for producing same |
| 06/05/2013 | EP2599502A2 Method for preparation of site-specific protein conjugates |
| 06/05/2013 | EP2599501A1 Adhesive patch for medical use |
| 06/05/2013 | EP2599500A1 Adhesive patch for medical use |
| 06/05/2013 | EP2599490A1 Anti-fatigue composition, formulation and use thereof |
| 06/05/2013 | EP2599486A1 Dronedarone solid dispersion and preparation method thereof |
| 06/05/2013 | EP2599484A1 Injectable pharmaceutical formulation of melphalan |
| 06/05/2013 | EP2599483A1 4-Phenylbutyric acid formulation |
| 06/05/2013 | EP2599479A1 4-phenylbutyric acid for the treatment of alzheimer's disease |
| 06/05/2013 | EP2599478A1 Transdermal therapeutic system for application of fentanyl or an analogue material thereof |
| 06/05/2013 | EP2599477A1 4-Phenylbutyric acid sustained release formulation |
| 06/05/2013 | EP2599476A1 Treatment of bladder dysfunction using liposomal botulinum toxin |
| 06/05/2013 | EP2599475A2 Pharmaceutical composition having desirable bioavailability |
| 06/05/2013 | EP2599473A1 Astaxanthin-containing aqueous composition, cosmetic preparation, and method for suppressing degradation of astaxanthin |
| 06/05/2013 | EP2599466A2 Injection molding device and method |
| 06/05/2013 | EP2599394A1 Embedded liquid lubricants for tableting |
| 06/05/2013 | EP2598553A1 Compositions comprising polymers prepared from 2-hydroxyalkyl acids |
| 06/05/2013 | EP2598522A2 Recombinant lectins, binding-site modified lectins and uses thereof |
| 06/05/2013 | EP2598198A1 Modular microneedle transport device |
| 06/05/2013 | EP2598160A2 Stabilization of fsh |
| 06/05/2013 | EP2598156A1 Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain |
| 06/05/2013 | EP2598151A1 Compositions for treating heartworm infestation |
| 06/05/2013 | EP2598148A2 Pharmaceutical compositions containing pemetrexed having extended storage stability |
| 06/05/2013 | EP2598141A2 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies |
| 06/05/2013 | EP2598140A2 Compounds and methods for skin repair |
| 06/05/2013 | EP2598132A1 Composition for the treatment and prevention of herpes simplex labialis |
| 06/05/2013 | EP2598124A1 Three-phase controlled-release tablet comprising melatonin and process of preparation |
| 06/05/2013 | EP2598123A1 Compositions |
| 06/05/2013 | EP2598122A2 Composition comprising shellac and/or a salt thereof and sodium starch glycolate |
| 06/05/2013 | EP2598121A1 A method of controlling the release of an active ingredient from a dosage form |
| 06/05/2013 | EP2598120A2 Compositions and methods for inducing immune tolerance |
| 06/05/2013 | EP2598119A2 Preservative free brimonidine and timolol solutions |
| 06/05/2013 | EP2598118A2 Preservative free bimatoprost and timolol solutions |
| 06/05/2013 | EP2598117A2 Preservative free bimatoprost solutions |
| 06/05/2013 | EP2598116A2 Ph-dependent gradual release pharmaceutical composition |
| 06/05/2013 | EP2598115A1 A transmucosal composition containing anthocyanins for alleviating a visual discomfort |